The prevalence of human papillomavirus (HPV) infection in female adolescents aged 14 to 19 years in the U.S. is nearly 25%. Despite the availability of vaccines protecting against both the cancer-causing strains of HPV (16 and 18) and wart-causing strains (6 and 11) since 2006, vaccination rates are low, partly because of a perception that vaccination may promote unsafe sexual activity among recipients.
To examine this issue, researchers assessed whether HPV vaccination status was associated with the rate of sexually transmitted infections (STIs) in female patients aged 12 to 18 years between 2005 and 2010, using a large database of insurance claims from U.S. employers. Results were as follows:
Reviewing Author
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)